AllovirInc exotic insider transaction detected
| ALVR Stock | USD 0.45 0.03 7.14% |
Slightly above 56% of Allovir's investor base is looking to short. The analysis of overall sentiment of trading Allovir stock suggests that many investors are alarmed at this time. Allovir's investing sentiment overview a quick insight into current market opportunities from investing in Allovir. Many technical investors use Allovir stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Allovir |
Filed transaction by Allovir Inc director. Unconventional Insider trading
Read at macroaxis.com
Allovir Fundamental Analysis
We analyze Allovir's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allovir using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allovir based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Allovir is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Allovir Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allovir stock to make a market-neutral strategy. Peer analysis of Allovir could also be used in its relative valuation, which is a method of valuing Allovir by comparing valuation metrics with similar companies.
Peers
Allovir Related Equities
| ACRV | Acrivon Therapeutics, | 16.34 | ||||
| ANAB | AnaptysBio | 9.28 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| INBX | Inhibrx | 5.90 | ||||
| ANEB | Anebulo Pharmaceuticals | 4.43 | ||||
| MLYS | Mineralys Therapeutics, | 4.08 | ||||
| CRNX | Crinetics Pharmaceuticals | 3.10 | ||||
| KRON | Kronos Bio | 3.09 | ||||
| BDTX | Black Diamond | 2.80 | ||||
| CGEM | Cullinan Oncology | 2.34 | ||||
| ANTX | AN2 Therapeutics | 2.16 | ||||
| MRUS | Merus BV | 2.03 | ||||
| STOK | Stoke Therapeutics | 1.95 | ||||
| FDMT | 4D Molecular | 1.72 | ||||
| AGIO | Agios Pharm | 1.10 | ||||
| AVTE | Aerovate Therapeutics | 0.37 | ||||
| ADAG | Adagene | 1.94 |
Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.